An Octopus Probe for High-Performance >1,300 Nm NIR-II Fluorescence Molecular Imaging of Cancer
Researchers at Stanford introduced the Octopus (OCTP) probe, a modular NIR‑II fluorescence agent that emits beyond 1,300 nm and targets the folate receptor. In pre‑clinical mouse studies, OCTP delivered markedly higher tumor‑to‑background ratios and brighter tumor signals than the FDA‑approved Cytalux probe. Its multi‑arm PEG architecture promotes rapid, sustained tumor uptake, swift renal clearance, and minimal off‑target toxicity. The technology promises more accurate intra‑operative margin detection, potentially reducing residual disease and preserving healthy tissue.
Re: Effectiveness of Interventions to Increase Vaccine Uptake: Component Network Meta-Analysis
Sunil Raina’s letter argues that trust, not logistics, is the core driver of vaccine uptake. He critiques the BMJ meta‑analysis for focusing on behavioral nudges while overlooking why people resist vaccines. The response highlights how reminders, community‑member involvement, and financial...
Why ‘Wound Closure’ Is The Wrong Metric for Trauma Surgery
The article argues that wound closure is an outdated success metric for trauma surgery, emphasizing that true recovery hinges on functional, aesthetic, and quality‑of‑life outcomes. It highlights regenerative technologies—autologous cell systems and dermal scaffolds—that deliver superior skin regeneration, reduce donor‑site...
Efforts to Eliminate Hepatitis Delivers Gains but More Action Needed to Meet 2030 Targets
The WHO’s 2026 Global Hepatitis Report shows progress since 2015, with a 32% drop in new hepatitis B infections and a 12% decline in hepatitis C deaths. Yet hepatitis B and C still caused 1.34 million deaths in 2024 and new...
Vitamin D Boosts Breast Cancer Treatment Success by 79%
Researchers at São Paulo State University conducted a randomized trial of 80 women over 45 undergoing neoadjuvant chemotherapy for breast cancer. One half received 2,000 IU of vitamin D daily, while the other took a placebo. After six months, 43% of the...
Viewpoint: Medical MJ Resked: Implications for Insurance Coverage, Capacity and Compliance
On April 23 the Department of Justice re‑classified state‑licensed medical marijuana and FDA‑approved cannabis products to Schedule III, easing the federal tax penalty under IRC 280E. The change removes a major financial headwind, improving margins for operators and opening the door for broader...
Tracking Health in Autistic Adults, and More
Two recent peer‑reviewed studies reveal that autistic adults experience markedly higher rates of type 2 diabetes, hypertension, obesity and inflammatory bowel disease, and that mortality is significantly greater for individuals diagnosed with autism in childhood compared with matched non‑autistic peers. The...
Why Healthcare AI Still Can’t Scale — and How Nvidia & Hoppr Are Trying to Fix It
Healthcare AI adoption is hampered by deployment and scaling challenges, prompting Nvidia and Hoppr to pivot from building standalone models to creating an AI foundry infrastructure. The foundry leverages Nvidia’s computing power and pre‑trained foundation models, allowing hospitals and radiology...
CMS Unveils Proposed 2028 HCBS Quality Measure Set: What It Means For Home Care Providers
The Centers for Medicare & Medicaid Services (CMS) has released a proposed set of 23 mandatory quality measures for Medicaid home‑ and community‑based services (HCBS) slated for 2028. The measures, which emphasize person‑centered outcomes such as safety, respect, and community...
True, OYMotion Pioneer Neuro AI Technology
True Corporation’s Research and Innovation Centre has teamed with neuro‑tech firm OYMotion to create a neuro‑AI platform that translates brain signals into commands for smart devices and prosthetics, aiming to accelerate rehabilitation. The system combines brain‑computer interface sensors, AI‑driven signal...
MyBrainCo Partners Pharmacy Veteran to Gain Ground in New Sales Channel
Australian nutraceutical brand myBrainCo has partnered with StirlingFildes Plus, a 90‑year‑old pharmacy solutions provider, to accelerate entry into the pharmacy channel. The partnership gives myBrainCo access to StirlingFildes’ network of roughly 5,000 pharmacies, far exceeding the reach of traditional wholesalers like...
GSK Singapore Launches National Shingles Awareness Campaign “Wait For What?”
GlaxoSmithKline Singapore, together with Klick Health, has launched a national shingles awareness campaign titled “Wait For What?” that runs from March through June 2026. The multilingual effort features local celebrities Chen Shu Cheng, Richard Low and Zhu Hou Ren and spans TV, radio, digital, out‑of‑home and healthcare...
Noninvasive Skull Sensor Prevents Brain Injuries in Critically Ill ICU Patients
A Brazilian startup, brain4care, has validated a non‑invasive skull sensor that monitors intracranial compliance in real time. In a five‑year study of critically ill neuro‑ICU patients, adding the sensor to standard guideline‑based care cut mortality from 37.3% to 5.9% and...
Strong Policies Required As Sugar Fuels Oral Health Crisis
The New Zealand Dental Association (NZDA) is urging the government to adopt stronger sugar‑reduction policies, warning that the current food environment fuels preventable oral disease, obesity and diabetes. It cites the WHO’s finding that 116 countries now tax sugary drinks...
CEO of For-Profit MA Plan Tells CMS “Pay Us Less”
Devoted Health CEO Ed Park told CMS at the Medicarians conference that the for‑profit Medicare Advantage (MA) plan would welcome lower government payments. He cited MedPAC’s March report showing MA enrollees cost the federal government $76 billion more than traditional Medicare....
How Big Is Organon’s Biosimilar Push for Sun Pharma?
Sun Pharma’s $11.75 billion acquisition of Organon propels the Indian drugmaker into the global biosimilars market, placing it among the top ten players. Organon’s biosimilar portfolio generated $691 million in 2025, about 11 % of its total revenue, with 45 % of that coming...
Bacteria-Resistant Coating on Catheters Reduces Infection and Need for Antibiotics
A clinical trial of Camstent's bacteria‑resistant polymer‑coated catheter showed a one‑third drop in catheter‑associated urinary tract infections (CAUTIs) and more than a 50 % reduction in antibiotic use versus standard catheters. Long‑term patients using the coated device reported zero symptomatic CAUTIs...
Nautilus Biotechnology Inc (NAUT) Q1 2026 Earnings Call Transcript
Nautilus Biotechnology reported a 23% drop in Q1 operating expenses to $15.4 million and ended the quarter with $156.1 million in cash, extending its runway into 2027. Management guided to modest $0.5 million revenue in 2026, primarily from grant‑funded early access customers, while...
AxoGen Inc (AXGN) Q1 2026 Earnings Call Transcript
Axogen reported Q2 2025 revenue of $56.7 million, an 18.3% year‑over‑year increase, and posted a modest net profit of $0.6 million, turning quarterly profitability. Gross margin rose to 74.2% and operating expenses fell as a share of revenue, highlighting operating leverage. The...
Zimmer Biomet Holdings, Inc (ZBH) Q1 2026 Earnings Call Transcript
Zimmer Biomet reported Q1 2026 net sales of $2.087 billion, a 9.3% increase on a reported basis and 2.9% organic constant‑currency growth. Adjusted earnings per share rose 15% to $2.09, helped by a $0.20 tariff benefit, while adjusted gross margin reached...
AbbVie (ABBV) Maintains Dividend Strength as Core Drugs Drive Cash Flow
AbbVie remains a strong dividend payer as its newer immunology drugs, Skyrizi and Rinvoq, now generate more revenue than Humira ever did. In 2025 the pair delivered $25.9 billion in sales, outpacing Humira’s 2022 peak of $21.2 billion. The company raised its...
How Virtual Reality Therapy Could Change the Way Mental Disorders Are Treated
Virtual reality (VR) is emerging as a powerful adjunct to cognitive‑behavioral therapy, allowing clinicians to immerse patients in realistic anxiety‑provoking scenarios such as public speaking or flying. A recent literature review in Psychology Research and Behavior Management confirms that VR‑enhanced...
CDER Proposes to Withdraw Approval of TAVNEOS
The FDA’s Center for Drug Evaluation and Research has proposed withdrawing approval of TAVNEOS (avacopan) after uncovering data manipulation in the pivotal trial and a lack of demonstrated efficacy for severe ANCA‑associated vasculitis. The agency also flagged new safety signals,...
How a Mental Health Strategy Helps Young Adults Navigate Cancer Diagnosis
Rutgers University researchers evaluated Bright IDEAS, a CBT‑based problem‑solving program, in a randomized trial of 344 young adults (18‑39) newly diagnosed with cancer. Participants who completed six video sessions showed significant reductions in depression and anxiety and reported higher health‑related...
ACA Marketplace Coverage Changes Reduce Hospital Revenue, Shift Payer Mix
Changes to ACA marketplace coverage in 2026 trimmed HCA Healthcare's adjusted EBITDA by $150 million in Q1, reflecting a 15% YoY drop in marketplace admissions and a rise in uninsured patients. The shift also slowed Medicaid conversions, as patients hesitate to...
Opportunistic AI Detects Colorectal Cancer Using Routine, Noncontrast CT
Researchers at Guangdong Provincial People’s Hospital unveiled COCA, an AI tool that detects colorectal cancer on routine non‑contrast abdominal and pelvic CT scans. In retrospective tests on more than 2,000 scans, COCA delivered an AUC between 0.967 and 0.996, boosting...
China Races to Build Record Biobank to Rival US Drugs Research
China is constructing a national biobank that will house blood and DNA samples from 33,000 children, targeting brain‑disease research. The initiative, led by the Chinese Institute for Brain Research, seeks to create a data‑rich platform that rivals the United States’...
The BioPharm Brief: FDA Advances Autoimmune Pipeline with New Delivery Options and Priority Review
The FDA cleared a subcutaneous autoinjector for anifrolumab, allowing at‑home treatment of moderate‑to‑severe systemic lupus erythematosus. It also granted Priority Review to nipocalimab for warm autoimmune hemolytic anemia, a rare blood disorder, accelerating its path to market. AbbVie submitted a...
Great Work Deserves to Be Seen: 2026 Innovator Awards Now Open
The Healthcare Innovation Innovator Awards Program has opened nominations for its 2026 cycle, inviting teams from hospitals, health systems, payers, and other providers to showcase technology‑driven improvements. The contest emphasizes team‑based recognition, allowing participants to submit concise stories that the...
Study Suggests Fibroid Rates in Latina Women May Be Lower than Previously Thought
A new Michigan Medicine study, the largest U.S. ultrasound‑confirmed investigation of uterine fibroids in Latina women, found an overall prevalence of 11.8%, notably lower than earlier estimates that reached 37%. The research, part of the ELLAS project and employing community‑based...
Timely by DrFirst Aims to Lower Barriers to Specialty Meds
Timely by DrFirst unveiled a provider‑focused solution that embeds actionable insights directly into e‑prescribing workflows. The tool boosts prior‑authorization (PA) completion to 60% for specialty drugs and cuts pharmacy change requests by 56%, while patient‑facing text messages achieve an 88%...
Conservative Physicians Accuse Medical Boards of Censorship
Two conservative physicians and a medical group asked the Fifth Circuit to revive claims that the American Board of Internal Medicine (ABIM) and the American Board of Obstetrics and Gynecology (ABOG) are threatening to strip board certifications for dissenting medical...
Georgian Mall Family Dental: Building Smiles and Trust
Georgian Mall Family Dental, founded in 2013 in Barrie, Ontario, built its brand around a patient‑first philosophy rather than rapid expansion. By locating inside a busy mall and creating a calm, hotel‑like environment, the clinic earned strong word‑of‑mouth referrals and...
April 30, 2026: Meeting of the Oncologic Drugs Advisory Committee Meeting Announcement - 04/30/2026
The FDA’s Oncologic Drugs Advisory Committee will meet on April 30, 2026 to evaluate two AstraZeneca submissions: NDA 220359 for camizestrant tablets combined with CDK4/6 inhibitors in ESR1‑mutated hormone‑receptor‑positive breast cancer, and sNDA 218197/S‑004 for Truqap (capivasertib) plus abiraterone in PTEN‑deficient metastatic hormone‑sensitive prostate...
‘It’s in Our DNA’: Nursing Home Giant PACS CEO on Compliance Transformation After Investigation, Growth, $100M Tech Investments
After a 2024 billing investigation, PACS Group (NYSE:PACS) revamped its compliance framework and poured roughly $100 million into technology, standardizing EMRs and real‑time dashboards across its 323 facilities. CEO Jason Murray says the changes have woven compliance into the company’s DNA,...
WVU Medicine Children’s Hospital Launches Breast Milk Donation Site
WVU Medicine Golisano Children’s Hospital in Morgantown has partnered with the Mid-Atlantic Mothers’ Milk Bank to operate a donor breast‑milk depot. The site allows screened donors to drop off milk, which is stored in the Little Mountaineer Pharmacy before being...
Viewpoint: Is AI Actually Improving Care Outcomes?
A recent correspondence in Nature Medicine argues that healthcare AI’s clinical benefits remain largely unproven. While many studies showcase algorithmic accuracy on retrospective data, they rarely assess real‑world patient outcomes. The authors, Jenna Wiens and Anna Goldenberg, call for randomized trials, prospective...
Building End-to-End, Intelligent Patient Flow at Scale
Health systems are turning to an integrated, AI‑driven operating model to streamline patient flow from admission to discharge. By unifying capacity management, admission planning, care progression, staff scheduling and discharge coordination, hospitals can anticipate bottlenecks and act proactively. Early adopters...
Beth Israel Lahey Health Names Network President
Boston‑based Beth Israel Lahey Health announced Sue Chapman Moss as president of its Performance Network. In the role, Moss will steer the clinically integrated network of physicians, clinicians and hospitals. She joins from Bayada Home Health Care, where she oversaw payer...
Intellia’s Data Reveal Tees Up FDA Filing for CRISPR-Based In Vivo Gene-Editing Med
Intellia Therapeutics filed a rolling FDA submission for lonvo‑z, its CRISPR‑based in‑vivo gene‑editing therapy for hereditary angioedema (HAE). In a placebo‑controlled Phase 3 trial of 80 patients, a single infusion cut swelling attacks by 87% versus placebo and left 62% of...
UVM Health Lays Off Staff at New York Hospitals
University of Vermont Health eliminated nine positions on April 14 at two New York hospitals—two at Alice Hyde Medical Center in Malone and seven at Champlain Valley Physicians Hospital in Plattsburgh. The layoffs are part of a broader effort to...
BMC South Workers Rescind Strike Notice
More than 475 registered nurses and healthcare workers at BMC South in Brockton rescinded a three‑day strike notice originally set for April 30 after progress was made in contract talks. The Massachusetts Nurses Association said the union will hold off on...
Cottage Health Formalizes Innovation with New Leadership Role
Cottage Health in Santa Barbara has created its first chief innovation officer role, appointing Dr. Ryan Kelly to lead the Compton Center for Medical Excellence and Innovation. The new office will formalize idea intake, evaluation and decision‑making processes, aiming for...
FDA Identifies Recall of Catheter Kits, Early Alert for Sterile Labels
The FDA announced a nationwide recall of Arrow International dialysis catheter kits that contain Merit Medical 16F Dual‑Valved Splittable Sheath Introducers because the sheath may not split as designed. Simultaneously, the agency issued an Early Alert for Omnicell i.v.STATION sterile...
UnitedHealth Completes Sale of UK Business to TPG
TPG has completed the acquisition of Optum UK, UnitedHealth Group’s subsidiary that owns EMIS Group, the software platform powering most NHS electronic patient records. The transaction, closed on March 13, was valued between £1.2 billion and £1.4 billion (approximately $1.5‑$1.8 billion). UnitedHealth reported $400 million...
Blog: (Re)Designing Care Delivery and Operating Models for the Future at the AHA Leadership Summit
The American Hospital Association’s 2025 Leadership Summit convened senior health‑care executives, clinicians, and innovators in Denver from July 12‑14, spotlighting new care‑delivery and operating‑model strategies. Key sessions examined AI‑enabled patient experiences, value‑based reimbursement, and integrated health networks. The AHA Board elected...
SBIA Resources in Chinese 中文信息
The FDA’s Small Business and Industry Assistance (SBIA) program has released Chinese-language versions of six recent webinars, covering critical topics such as the Drug Supply Chain Security Act, establishment registration, electronic submission requirements, eCTD data standards, GDUFA II, and generic drug...
HIMSS26 Changemaker Advocates for Health IT Causes
At HIMSS26, federal lobbyist Brett Meeks of Jeffrey J. Kimbell & Associates highlighted his daily mission to advance health‑IT interoperability and data privacy. Speaking as a Changemaker, Meeks emphasized the urgency of unified data standards as AI becomes embedded in...
Medicaid Administrative Burden Hits Providers
A Gainwell Technologies survey of 309 Medicaid providers reveals that 28% are dissatisfied with administrative processes, making them 3.9 times more likely to leave the program within three years. Dissatisfaction is driving a quarter of skilled nursing facilities, physician groups...
FDA Grants Breakthrough Designation for Efimosfermin for MASH
GSK’s investigational liver drug efimosfermin received FDA breakthrough therapy designation for metabolic dysfunction‑associated steatohepatitis (MASH). A phase‑2 trial showed 45.2% of patients achieved at least one‑stage fibrosis improvement versus 20.6% on placebo, and 67.7% attained MASH resolution compared with 29.4%...